A wearable prognostic device that can monitor and track the functional recovery of patients undergoing physiotherapy
HYDERABAD, Apr4(The CONNECT) – Startoon Labs Private Limited, a Hyderabad-based medical device R&D and Manufacturing Company with a focus on joint and muscle health, announced that it has signed an MOU with Medplus, a prominent pharmacy retail chain, to initiate the Pheezee assessment in the Medplus diagnostic centres.
Pheezee, a Hyderabad startup’s Joint health monitoring device and USFDA listed, is a first of its kind in the world. It is a wearable prognostic device that can monitor and track the functional recovery of patients undergoing physiotherapy. By generating AI-enabled reports that include valuable insights on affected muscles, along with the impressions and Personalized recommendations, it helps the physiotherapist with the right assessment, thereby aiming for faster and effective patient recovery.
Medplus Diagnostics offers pathology and radiology services. It is a part of Medplus health services, which is known for its pharmacy retail chain. It is now introduced the muscle & joint health diagnostics by using the Pheezee device.
With the Pheezee introduction, Medplus now offers a cutting-edge solution to patients and healthcare professionals seeking accurate and timely intervention. Using Pheezee, it can do a pain diagnostic test and give a report which can identify the root cause of pain, especially for ageing and posture-related pains.
Pheezee test is useful for patients suffering from joint and muscle pain. It helps to identify the exact root cause of the pain and pinpoint the affected muscle. So that, instead of treating the entire joint, it can be useful for the doctors to treat the affected muscle only. Pheezee test can be taken by people having musculoskeletal pains and neurological conditions.
A study focusing on individuals aged 45 years and above reported that approximately 50% experienced joint pain, about 33% suffered from back pain, and around 20% had ankle or foot pain. A national survey states that the most commonly affected sites were the knee (8.5%), back (6.2%), ankle (3.8%), shoulder (3.2%), elbow (2.9%), hand/wrist (2.9%) and neck (1.5%). A study among IT professionals in India reported that 64.9% experienced neck pain, 19.8% experienced wrist pain, and 42.1% reported shoulder pain.
Disclosing this in a press note issued in Hyderabad, Dr. Srivani, Physiotherapist, said that, Pheezee is a powerful device that evaluates muscle function and nerve communication that enables precise diagnosis conditions such as joint pains and muscle disorders.
Pheezee test is a non-invasive test for joints, which brings out the important diagnostic physiological information which is not captured in the prevalent imaging diagnostic tools like X-Ray, MRI and CT scans! A Pheezee Test report, along with the other static image reports, gives a detailed and comprehensive picture of the joints, adding great value to Orthopedics and Neurologists during their clinical diagnosis and patient counselling, says Mr. Suresh Susurla, CEO and Co-founder of Startoon Labs.
Our renowned customers like Tapadia, Anvayaa and TGSRTC rely on Pheezee to enhance the well-being of the Patients. TGSRTC in particular, uses Pheezee to assess pain in their drivers, which enables them to improve their Operational efficiency.
Mythreyi Kondapi, CTO & Co-founder of Startoon Labs, stated, “Introducing Pheezee at Medplus is a game-changer in the field of muscle diagnostics”.
Millions of patients suffering from nerve and muscle disorders often go undiagnosed due to limited access to advanced testing facilities. To address this critical need, Pheezee leverages cutting-edge technology like Electromyography and Range of Motion analysis to accurately measure and track patient recovery post-musculoskeletal and neurological disorders. This device is able to identify multiple musculoskeletal diseases, including arthritis, muscle dystrophy, carpal tunnel syndrome and many more in their early stages and can ensure better rehabilitation outcomes for the patients.
This collaboration is a proud moment for both Startoon Labs and Medplus. What could be a better moment than introducing the joint health assessments for the patients in the diagnostic centre?
As a part of the rapidly growing MedTech industry in India, valued at $ 15.35 billion in 2023, Startoon Labs is at the forefront of the digital technology segment. The sector is expected to grow to $20.51 billion by 2029 with a CAGR of 5.35%. The Indian medical device market share in the global market is estimated to be 1.65%.
